SNBL Clinical Pharmacology Center primarily conducts Phase I studies, the first stage of research where a drug is introduced into human populations. Phase I studies are most concerned with assessing a drug’s safety and tolerability. These assessments are performed by studying how the human body absorbs, distributes, metabolizes, and excretes the drug, and by investigating any side effects at various dosage levels.
Our facility in Baltimore, Maryland, in the University of Maryland’s BioPark, is easily accessible from all points along the East Coast via train and I-95.
Baltimore Clinical Trials is SNBL Clinical Pharmacology Center’s information page for volunteers. Here volunteers can find out about upcoming studies, information about our facility, general information about the nature of Phase I studies, and links to our Facebook and Twitter profiles.